Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

TGF-8027

From Wikipedia, the free encyclopedia

Pharmaceutical compound
TGF-8027
Clinical data
Other namesTGF8027; TGF-8-027;N-[1-(2-Hydroxyphenyl)ethyl]-2,5-dimethoxy-4-cyanophenethylamine
Drug classSelectiveserotonin5-HT2A receptoragonist;Serotonergic psychedelic;Hallucinogen
ATC code
  • None
Chemical and physical data
FormulaC19H22N2O3
Molar mass326.396 g·mol−1
3D model (JSmol)
  • C1=C(C#N)C(OC)=CC(CCN([H])C(C)C2=CC=CC=C2O[H])=C1OC
  • InChI=1S/C19H22N2O3/c1-13(16-6-4-5-7-17(16)22)21-9-8-14-10-19(24-3)15(12-20)11-18(14)23-2/h4-7,10-11,13,21-22H,8-9H2,1-3H3
  • Key:YGVDYCKUVCKBFS-UHFFFAOYSA-N

TGF-8027, orTGF-8-027, also known asN-[1-(2-hydroxyphenyl)ethyl]-2,5-dimethoxy-4-cyanophenethylamine, is a highlyselectiveserotonin5-HT2A receptoragonist and putativeserotonergic psychedelic of thephenethylamine,2C, and25-NB (NBOH) families.[1] It is one of the most selective serotonin 5-HT2A receptor agonists known and shows much greater selectivity than earlier agents like25CN-NBOH,DMBMPP, andLPH-5.[1] The drug produces psychedelic-like effects in rodents and hence may behallucinogenic in humans.[1] TGF-8027 was first described in the literature in 2025.[1]

Interactions

[edit]
See also:Psychedelic drug § Interactions, andTrip killer § Serotonergic psychedelic antidotes

Pharmacology

[edit]

Pharmacodynamics

[edit]

TGF-8027 acts as a highlyselectiveserotonin5-HT2A receptorfull agonist.[1] Itsaffinities (Ki) were 7.4 nM at the serotonin 5-HT2A receptor, 390 nM at the serotonin5-HT2B receptor, and 1,100 nM at the serotonin5-HT2C receptor.[1] The drug'sEC50Tooltip half-maximal effective concentration andEmaxTooltip maximal efficacy values in terms ofGq dissociation were 3.3 nM (91%) at the human serotonin 5-HT2A receptor, 7,600 nM (45%) at the human serotonin 5-HT2B receptor, and 160 nM (123%) at the human serotonin 5-HT2C receptor.[1] It was also assessed at these receptors with otherassays.[1] In addition, TGF-8027 was screened at a large panel of othertargets, includingreceptors andtransporters, and showed relatively littleaffinity at these sites.[1]

With regard to selectivity for the human serotonin 5-HT2A receptor over the human serotonin 5-HT2C receptor, TGF-8027 showed 149-fold selectivity in terms of affinity, 48.5-fold selectivity in terms of Gq dissociation, 84.5-fold selectivity in terms ofcalcium flux, and 2,450-fold selectivity in terms ofIP1 accumulation.[1] It is far more selective as an agonist of the serotonin 5-HT2A receptor over the serotonin 5-HT2C receptor than previous selective serotonin 5-HT2A receptor agonists such as25CN-NBOH,DMBMPP, andrac-LPH-5 (fold selectivity for Gq dissociation in the same study of 10.0, 13.5, and 4.4, respectively).[1] Previous research had not rigorously assessed the selectivity of these earlier compounds via employment of multiple selectivity assays.[1]

TGF-8027 was less selective for the mouse serotonin 5-HT2A receptor over the mouse serotonin 5-HT2C receptor, but still showed about 15-fold selectivity for the former over the latter in terms of Gq dissociation.[1] In accordance with its serotonin 5-HT2A receptor activation, the drug robustly induces thehead-twitch response, a behavioral proxy of psychedelic effects, in mice.[1] As such, it would be expected to produce psychedelic effects in humans.[1]

The compound is aracemic mixture of (+)- and (–)-enantiomers, with the (–)-enantiomer being a morepotent serotonin 5-HT2A receptor agonist but the (+)-enantiomer being more selective for activation of the serotonin 5-HT2A receptor over the serotonin 5-HT2C receptor.[1]

Chemistry

[edit]

TGF-8027, also known asN-[1-(2-hydroxyphenyl)ethyl]-2,5-dimethoxy-4-cyanophenethylamine, is asubstituted phenethylamine and a2C and25-NB (NBOH)derivative.[1] It is specifically the derivative of25CN-NBOH in which thebenzyl group has beenα-methylated.[1] The compound is aracemic mixture of (+)- and (–)-enantiomers.[1] A series of otheranalogues of TGF-8027 have also been reported, some of which show further improved serotonin 5-HT2A receptor selectivity relative to TGF-8027 itself.[1]

History

[edit]

TGF-8027 was first described in thescientific literature by John McCorvy's lab and colleagues in 2025.[1] The group also includedAdam Halberstadt.[1] The serotonin 5-HT2A and 5-HT2C receptors show considerablehomology, which has made development of selective serotonin 5-HT2A receptor agonists difficult.[1] TGF-8027 was discovered via arationalstructure-guided design that took advantage of an identified single-residue difference between the serotonin 5-HT2A receptor and the serotonin 5-HT2C receptor intransmembrane 2 (TM2) of the extended binding pocket.[1] The group also reported a series of other selective serotonin 5-HT2A receptor agonists in addition to TGF-8027, some of which showed even further improved selectivity.[1] TGF-8027 was selected for more in-depth characterization over other compounds, for instance in thehead-twitch response assay, because it showed among the highest selectivity andpotency at the mouse serotonin 5-HT2A receptor in addition to the human serotonin 5-HT2A receptor.[1]

Society and culture

[edit]

Legal status

[edit]

Canada

[edit]

TGF-8027 may be acontrolled substance inCanada under phenethylamine blanket-ban language.[2]

United States

[edit]

TGF-8027 is not an explicitlycontrolled substance in theUnited States.[3] However, it could be considered a controlled substance under theFederal Analogue Act if intended for human consumption.

See also

[edit]

References

[edit]
  1. ^abcdefghijklmnopqrstuvwxyzFenske TG, McKee JL, Cavalco NG, Schalk SS, Bonniwell EM, Lammers JC, et al. (September 2025). "Discovery of Highly Selective 5-HT2A Agonists Using Structure-Guided Design".J Med Chem acs.jmedchem.5c01855.doi:10.1021/acs.jmedchem.5c01855.PMID 40997862.
  2. ^"Controlled Drugs and Substances Act".Department of Justice Canada. Retrieved19 January 2026.
  3. ^Orange Book: List of Controlled Substances and Regulated Chemicals (January 2026)(PDF),United States: U.S.Department of Justice:Drug Enforcement Administration (DEA): Diversion Control Division, January 2026

External links

[edit]


Tryptamines
No ring subs.
4-Hydroxytryptamines
5-Hydroxytryptamines
5-Methoxytryptamines
Other ring subs.
α-Alkyltryptamines
Others
Cyclized
Bioisosteres
Phenethylamines
Scalines
2C-x
3C-x
DOx
4C-x
Ψ-PEA
MDxx
FLY
25x-NB (NBOMes)
Others
Cyclized
Lysergamides
Others
Natural sources
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
Phenethylamines
Amphetamines
Phentermines
Cathinones
Phenylisobutylamines
(and further-extended)
Catecholamines
(and close relatives)
Cyclized
phenethylamines
Phenylalkylpyrrolidines
2-Benzylpiperidines
(phenidates)
Phenylmorpholines
(phenmetrazines)
Phenyloxazolamines
(aminorexes)
Isoquinolines and
tetrahydroisoquinolines
2-Aminoindanes
2-Aminotetralins
Others / unsorted
Related compounds
Retrieved from "https://en.wikipedia.org/w/index.php?title=TGF-8027&oldid=1334214201"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2026 Movatter.jp